• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WD40 结构域对于 LRRK2 的神经毒性是必需的。

The WD40 domain is required for LRRK2 neurotoxicity.

机构信息

Department of Neurology, Columbia University Medical Center, New York, New York, United States of America.

出版信息

PLoS One. 2009 Dec 24;4(12):e8463. doi: 10.1371/journal.pone.0008463.

DOI:10.1371/journal.pone.0008463
PMID:20041156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2794542/
Abstract

BACKGROUND

Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson disease (PD). LRRK2 contains an "enzymatic core" composed of GTPase and kinase domains that is flanked by leucine-rich repeat (LRR) and WD40 protein-protein interaction domains. While kinase activity and GTP-binding have both been implicated in LRRK2 neurotoxicity, the potential role of other LRRK2 domains has not been as extensively explored.

PRINCIPAL FINDINGS

We demonstrate that LRRK2 normally exists in a dimeric complex, and that removing the WD40 domain prevents complex formation and autophosphorylation. Moreover, loss of the WD40 domain completely blocks the neurotoxicity of multiple LRRK2 PD mutations.

CONCLUSION

These findings suggest that LRRK2 dimerization and autophosphorylation may be required for the neurotoxicity of LRRK2 PD mutations and highlight a potential role for the WD40 domain in the mechanism of LRRK2-mediated cell death.

摘要

背景

富含亮氨酸重复激酶 2(LRRK2)的突变是帕金森病(PD)最常见的遗传原因。LRRK2 包含由 GTPase 和激酶结构域组成的“酶核心”,其两侧为富含亮氨酸重复(LRR)和 WD40 蛋白-蛋白相互作用结构域。虽然激酶活性和 GTP 结合都与 LRRK2 的神经毒性有关,但其他 LRRK2 结构域的潜在作用尚未得到广泛探索。

主要发现

我们证明 LRRK2 通常以二聚体复合物的形式存在,并且去除 WD40 结构域会阻止复合物形成和自身磷酸化。此外,丧失 WD40 结构域完全阻止了多种 LRRK2 PD 突变的神经毒性。

结论

这些发现表明 LRRK2 二聚化和自身磷酸化可能是 LRRK2 PD 突变神经毒性所必需的,并突出了 WD40 结构域在 LRRK2 介导的细胞死亡机制中的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/4511560dd82c/pone.0008463.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/825e0bf895b6/pone.0008463.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/33e47577f30b/pone.0008463.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/e6b8319bb9f9/pone.0008463.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/4511560dd82c/pone.0008463.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/825e0bf895b6/pone.0008463.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/33e47577f30b/pone.0008463.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/e6b8319bb9f9/pone.0008463.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/2794542/4511560dd82c/pone.0008463.g004.jpg

相似文献

1
The WD40 domain is required for LRRK2 neurotoxicity.WD40 结构域对于 LRRK2 的神经毒性是必需的。
PLoS One. 2009 Dec 24;4(12):e8463. doi: 10.1371/journal.pone.0008463.
2
Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain.富含亮氨酸重复序列激酶2通过其C末端WD40结构域介导的蛋白质相互作用与神经囊泡结合。
Mol Cell Biol. 2014 Jun;34(12):2147-61. doi: 10.1128/MCB.00914-13. Epub 2014 Mar 31.
3
Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.富含亮氨酸重复序列激酶2的富含亮氨酸重复序列同名结构域的表达、纯化及初步生化和结构表征
Biochim Biophys Acta. 2012 Mar;1824(3):450-60. doi: 10.1016/j.bbapap.2011.12.009. Epub 2012 Jan 11.
4
Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities.富含亮氨酸重复激酶 2(LRRK2)GTP 酶结构域中的自身磷酸化修饰激酶和 GTP 结合活性。
J Mol Biol. 2011 Sep 9;412(1):94-110. doi: 10.1016/j.jmb.2011.07.033. Epub 2011 Jul 22.
5
Crystal structure of the WD40 domain dimer of LRRK2.LRRK2 的 WD40 结构域二聚体的晶体结构。
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1579-1584. doi: 10.1073/pnas.1817889116. Epub 2019 Jan 11.
6
Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.LRRK2 激酶活性依赖于二聚化。
J Biol Chem. 2009 Dec 25;284(52):36346-36356. doi: 10.1074/jbc.M109.025437. Epub 2009 Oct 13.
7
Unique functional and structural properties of the LRRK2 protein ATP-binding pocket.LRRK2蛋白ATP结合口袋独特的功能和结构特性。
J Biol Chem. 2014 Nov 21;289(47):32937-51. doi: 10.1074/jbc.M114.602318. Epub 2014 Sep 16.
8
Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations.嗜热栖热菌Roc-COR中Roc结构域的构象异质性及其对人类LRRK2帕金森突变的影响。
Biosci Rep. 2015 Aug 26;35(5):e00254. doi: 10.1042/BSR20150128.
9
Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment.ROCO激酶的同源和异源二聚化:LRRK2的ROCO片段对LRRK2激酶的抑制作用
J Neurochem. 2009 Nov;111(3):703-15. doi: 10.1111/j.1471-4159.2009.06358.x. Epub 2009 Aug 27.
10
Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease.LRRK2 的生化和分子特征及其在帕金森病中的病理生理作用。
BMB Rep. 2010 Apr;43(4):233-44. doi: 10.5483/bmbrep.2010.43.4.233.

引用本文的文献

1
Functionally active modulators targeting the LRRK2 WD40 repeat domain identified by FRASE-bot in CACHE Challenge #1.通过FRASE-bot在CACHE挑战#1中鉴定出的靶向LRRK2 WD40重复结构域的功能活性调节剂。
Chem Sci. 2025 Jan 9;16(8):3430-3439. doi: 10.1039/d4sc07532c. eCollection 2025 Feb 19.
2
Cell-autonomous role of leucine-rich repeat kinase in the protection of dopaminergic neuron survival.富亮氨酸重复激酶在保护多巴胺能神经元存活中的细胞自主作用。
Elife. 2024 Jun 10;12:RP92673. doi: 10.7554/eLife.92673.
3
Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C-Symmetric Dimer in a Drosophila Model of Parkinson's Disease.

本文引用的文献

1
The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration.在神经退行性变的细胞模型中,帕金森病相关蛋白富含亮氨酸重复序列激酶2通过死亡结构域相关蛋白Fas和半胱天冬酶-8转导死亡信号。
J Neurosci. 2009 Jan 28;29(4):1011-6. doi: 10.1523/JNEUROSCI.5175-08.2009.
2
Intramolecular activation mechanism of the Dictyostelium LRRK2 homolog Roco protein GbpC.盘基网柄菌LRRK2同源物Roco蛋白GbpC的分子内激活机制
J Biol Chem. 2008 Oct 31;283(44):30412-20. doi: 10.1074/jbc.M804265200. Epub 2008 Aug 14.
3
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.
营养保健品脱氢姜酮及其 C-对称二聚体在帕金森病果蝇模型中的神经保护作用。
Biomolecules. 2024 Feb 24;14(3):273. doi: 10.3390/biom14030273.
4
Role of the leucine-rich repeat protein kinase 2 C-terminal tail in domain cross-talk.富含亮氨酸重复蛋白激酶 2 C 端尾部在结构域串扰中的作用。
Biochem J. 2024 Feb 21;481(4):313-327. doi: 10.1042/BCJ20230477.
5
Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease.帕金森病中ATIC 通过 ARE 介导的 mRNA 衰减调控 LRRK2 mRNA 的稳定性及其底物 AICAR。
EMBO J. 2023 Aug 1;42(15):e113410. doi: 10.15252/embj.2022113410. Epub 2023 Jun 27.
6
Genetic variations in and genes: Biochemical and clinical consequences in Parkinson disease.基因和基因的遗传变异:帕金森病的生化及临床后果
Front Neurol. 2022 Aug 12;13:971252. doi: 10.3389/fneur.2022.971252. eCollection 2022.
7
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease.帕金森病LRRK2 G2385R风险变异体的病理生理学评估
NPJ Parkinsons Dis. 2022 Aug 5;8(1):97. doi: 10.1038/s41531-022-00367-y.
8
LRRK2 Targeting Strategies as Potential Treatment of Parkinson's Disease.LRRK2 靶向策略作为帕金森病的潜在治疗方法。
Biomolecules. 2021 Jul 26;11(8):1101. doi: 10.3390/biom11081101.
9
A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson's Disease Affects LRRK2 Protein Levels.一种新的 LRRK2 变异体 p.G2294R 位于 WD40 结构域中,在家族性帕金森病中被发现,该变异体影响 LRRK2 蛋白水平。
Int J Mol Sci. 2021 Apr 2;22(7):3708. doi: 10.3390/ijms22073708.
10
LRRK2 at the Crossroad of Aging and Parkinson's Disease.LRRK2 在衰老和帕金森病的交叉路口。
Genes (Basel). 2021 Mar 29;12(4):505. doi: 10.3390/genes12040505.
LRRK2对4E-BP的磷酸化作用影响果蝇中多巴胺能神经元的维持。
EMBO J. 2008 Sep 17;27(18):2432-43. doi: 10.1038/emboj.2008.163. Epub 2008 Aug 14.
4
Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase.嗜热栖热菌(C. tepidum)的Roc-COR结构域串联体结构,人类LRRK2帕金森激酶的原核同源物。
EMBO J. 2008 Aug 20;27(16):2239-49. doi: 10.1038/emboj.2008.150. Epub 2008 Jul 24.
5
Ancient origin of the Parkinson disease gene LRRK2.帕金森病基因LRRK2的古老起源。
J Mol Evol. 2008 Jul;67(1):41-50. doi: 10.1007/s00239-008-9122-4. Epub 2008 Jun 4.
6
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.与帕金森病相关的富含亮氨酸重复序列激酶2(LRRK2)是一种会发生分子内自磷酸化的二聚体。
J Biol Chem. 2008 Jun 13;283(24):16906-14. doi: 10.1074/jbc.M708718200. Epub 2008 Apr 8.
7
The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.热休克蛋白90的伴侣活性对于维持富含亮氨酸重复激酶2的稳定性至关重要。
J Neurosci. 2008 Mar 26;28(13):3384-91. doi: 10.1523/JNEUROSCI.0185-08.2008.
8
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase.帕金森病相关富含亮氨酸重复激酶2的ROC结构域揭示了一种二聚体GTP酶。
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1499-504. doi: 10.1073/pnas.0709098105. Epub 2008 Jan 29.
9
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules.富含亮氨酸重复激酶2的Roc结构域足以与微管相互作用。
J Neurosci Res. 2008 Jun;86(8):1711-20. doi: 10.1002/jnr.21622.
10
Lrrk2 in the limelight!亮氨酸重复激酶2成为焦点!
Neurology. 2007 Oct 30;69(18):1732-3. doi: 10.1212/01.wnl.0000279588.20391.88.